biotech · Malignant Glioma · Prostate Cancer · CADL
Candel Therapeutics
Candel Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
117 Kendrick Street, Suite 450, Needham, Massachusetts 02494, US HQ
1999 Founded
82 Employees
Public company Type
CADL · NYSE Ticker
Company details
- Status
- Public
- HQ
- 117 Kendrick Street, Suite 450, Needham, Massachusetts 02494, US
- Founded
- 1999
- Employees
- 82
- Programs
- 12
- Drugs
- 4
- Patents
- 0
Candel Therapeutics clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Candel Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Candel Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Candel Therapeutics.
-
CAN-2409 + valacyclovir — Phase 1
Clinical update -
aglatimagene besadenovec + valacyclovir — Phase 2
Clinical update -
Aglatimagene besadenovec + valacyclovir — Phase 3
Clinical update -
AdV-tk + valacyclovir — Phase 1
Clinical update -
rQNestin — Phase 1
Clinical update -
CAN-2409 — Phase 2
Clinical update -
AdV-tk — Phase 1
Clinical update -
AdV-tk — Phase 1
Clinical update